Annual report pursuant to Section 13 and 15(d)

Stock Options (Details Narrative)

v3.8.0.1
Stock Options (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]    
Number of stock options granted 13,210,000 5,860,000
Exercise price of common stock granted $ 0.17 $ 0.09
Expiration period 3 years 5 years
Fair value of stock options grants $ 1,781,000 $ 462,000
Expected term 4 years 5 years
Risk free interest rate 1.92% 1.23%
Volatility rate 230.00% 123.00%
Dividend yield 0.00% 0.00%
Expense recognized relating to stock options $ 418,389  
Unrecognized stock based compensation expense $ 837,120 $ 457,881